中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
6期
150-152
,共3页
尿总蛋白肌酐比%分组%评价%糖尿病%肾损伤%价值
尿總蛋白肌酐比%分組%評價%糖尿病%腎損傷%價值
뇨총단백기항비%분조%평개%당뇨병%신손상%개치
Total urinary ACR%Grouping%Evaluation%Diabetes%Kidney injury%Values
目的:调查研究尿总蛋白肌酐比在评定糖尿病早期肾损伤的临床应用性及价值。方法选取在我院进行治疗的患者200例,根据其是否患有糖尿病将其分为两组:实验组(糖尿病患者组)100例;对照组(正常患者组)100例。而后分别测定两组患者的尿液指标,观察其各评定情况对糖尿病早期肾损伤的诊断结果。结果实验组与对照组两组患者的尿总蛋白肌酐比差异明显高于LAP、ALB等指标的的差异情况,且差异显著,具有统计学意义(P<0.05)。结论检测患者体内的尿总蛋白肌酐比对临床上糖尿病早期肾损伤具有诊断意义,发挥着不可忽视的临床应用价值。
目的:調查研究尿總蛋白肌酐比在評定糖尿病早期腎損傷的臨床應用性及價值。方法選取在我院進行治療的患者200例,根據其是否患有糖尿病將其分為兩組:實驗組(糖尿病患者組)100例;對照組(正常患者組)100例。而後分彆測定兩組患者的尿液指標,觀察其各評定情況對糖尿病早期腎損傷的診斷結果。結果實驗組與對照組兩組患者的尿總蛋白肌酐比差異明顯高于LAP、ALB等指標的的差異情況,且差異顯著,具有統計學意義(P<0.05)。結論檢測患者體內的尿總蛋白肌酐比對臨床上糖尿病早期腎損傷具有診斷意義,髮揮著不可忽視的臨床應用價值。
목적:조사연구뇨총단백기항비재평정당뇨병조기신손상적림상응용성급개치。방법선취재아원진행치료적환자200례,근거기시부환유당뇨병장기분위량조:실험조(당뇨병환자조)100례;대조조(정상환자조)100례。이후분별측정량조환자적뇨액지표,관찰기각평정정황대당뇨병조기신손상적진단결과。결과실험조여대조조량조환자적뇨총단백기항비차이명현고우LAP、ALB등지표적적차이정황,차차이현저,구유통계학의의(P<0.05)。결론검측환자체내적뇨총단백기항비대림상상당뇨병조기신손상구유진단의의,발휘착불가홀시적림상응용개치。
Objective To investigate the clinical application and value of total urinary ACR in evaluation of early diabetic kidney injury. Methods 200 patients treated in our hospital were divided them into two groups according to whether they had diabetes or not:100 cases in the experimental group(diabete patients group);100 cases in the control group(normal patients group).Then determined the urine of patients indicators in two groups,observed clinical results of watch evaluation situation on diabetic kidney injury in early diagnosis. Results The differences of total urinary ACR between experimental group and control group were significantly higher than other indicators such as LAP and ALB,and the differences were statistically significant(P < 0.05). Conclusion Detection of total urinary ACR in patients has great clinical significances for early diabetic kidney injury patiens,playing an ignored value in clinic.